)
Anjali Singh covers the automobile and pharmaceutical sectors, focusing on trends, policy developments, regulatory changes, industry expectations, corporate results among others. A postgraduate in communication journalism, she has a strong inclination towards data-driven reporting and enjoys breaking down complex topics to make them interesting and relevant for readers.
Anjali Singh covers the automobile and pharmaceutical sectors, focusing on trends, policy developments, regulatory changes, industry expectations, corporate results among others. A postgraduate in communication journalism, she has a strong inclination towards data-driven reporting and enjoys breaking down complex topics to make them interesting and relevant for readers.
After nearly 12% growth in FY26, CV industry to grow around 6-7% in FY27 amid headwinds from oil price volatility, monsoon-linked rural demand and macroeconomic pressures
Volkswagen India launches updated Taigun at Rs 10.99 lakh, introduces a buyback programme and adds features to attract buyers amid rising competition in the compact SUV segment
Ola Electric has launched the S1 X+ scooter with a 5.2 kWh battery, aiming to expand reach in the mass market amid declining market share and rising competition
Scaling the two-wheeler segment presents structural challenges for e-motorcycles
Health reports flag rising early-onset risks among younger Indians, highlighting need for preventive care as multiple conditions emerge undetected
Mahindra and Swaraj Tractors raise prices across domestic range citing commodity cost pressures, with hikes varying by model and region
BMW Group India leads quarterly registrations over Mercedes-Benz as luxury car demand plateaus, with EV segment growth providing a limited boost
Geopolitical uncertainties and concerns over a below-average monsoon remain overhang for FY27
Two-wheeler makers post strong FY26 growth led by rural recovery, scooter demand and premium motorcycles, though FY27 outlook may soften amid global headwinds
Electric vehicle sales rose sharply in FY26, driven by strong growth in two- and four-wheelers and a robust year-end push, as per Vahan registration data
Glenmark will directly manage Ryaltris sales in the US from April 2026, strengthening its innovation-led portfolio and expanding its commercial presence in the market
Biocon Limited names Shreehas Tambe CEO, outlines AI-led, integration-driven strategy to boost global biosimilars and generics growth
As semaglutide goes off patent, doctors warn of misuse by non-obese individuals amid rising demand driven by social media and lower-cost generics
EV maker reallocates ₹575 crore from R&D to debt repayment and growth as sales slow, market share slips and fundraising challenges persist
Automaker to raise prices across ICE passenger vehicles by 0.5% from April 1, citing sustained rise in input costs; impact will vary across models and variants
Lilly positions tirzepatide as a clinically superior option as semaglutide patent expiry triggers a wave of generics, intensifying competition in India's diabetes and obesity market
Novo Nordisk says competition in semaglutide will be driven by science and quality, not pricing, as multiple generic versions prepare to enter India after patent expiry
Lupin and Zydus Lifesciences enter a licensing pact to co-market semaglutide injection in India, aiming to improve access to therapies for diabetes and obesity
With the war showing no signs of abating, the outlook for many sectors of India's industry is clouding over right now
Ferrari unveiled the 849 Testarossa in India, signalling a deeper push into the fast-growing luxury car market as rising wealth and a new generation of collectors fuel demand